Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry
Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this stu...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
López-Otero, Diego [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A brief review on experimental fluorosis - Perumal, Ekambaram ELSEVIER, 2013, publicación oficial de la Sociedad Española de Cardiologia, Madrid |
|---|---|
| Übergeordnetes Werk: |
volume:74 ; year:2021 ; number:2 ; pages:175-182 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.rec.2020.05.018 |
|---|
| Katalog-ID: |
ELV052849937 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV052849937 | ||
| 003 | DE-627 | ||
| 005 | 20230624190338.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.rec.2020.05.018 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001275.pica |
| 035 | |a (DE-627)ELV052849937 | ||
| 035 | |a (ELSEVIER)S1885-5857(20)30224-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 082 | 0 | 4 | |a 540 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 42.13 |2 bkl | ||
| 084 | |a 44.33 |2 bkl | ||
| 100 | 1 | |a López-Otero, Diego |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry |
| 264 | 1 | |c 2021 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. | ||
| 650 | 7 | |a Angiotensin-converting enzyme inhibitors |2 Elsevier | |
| 650 | 7 | |a COVID-19 |2 Elsevier | |
| 650 | 7 | |a Angiotensin receptor blockers |2 Elsevier | |
| 700 | 1 | |a López-Pais, Javier |4 oth | |
| 700 | 1 | |a Cacho-Antonio, Carla Eugenia |4 oth | |
| 700 | 1 | |a Antúnez-Muiños, Pablo José |4 oth | |
| 700 | 1 | |a González-Ferrero, Teba |4 oth | |
| 700 | 1 | |a Pérez-Poza, Marta |4 oth | |
| 700 | 1 | |a Otero-García, Óscar |4 oth | |
| 700 | 1 | |a Díaz-Fernández, Brais |4 oth | |
| 700 | 1 | |a Bastos-Fernández, María |4 oth | |
| 700 | 1 | |a Bouzas-Cruz, Noelia |4 oth | |
| 700 | 1 | |a Sanmartín-Pena, Xoan Carlos |4 oth | |
| 700 | 1 | |a Varela-Román, Alfonso |4 oth | |
| 700 | 1 | |a Portela-Romero, Manuel |4 oth | |
| 700 | 1 | |a Valdés-Cuadrado, Luis |4 oth | |
| 700 | 1 | |a Pose-Reino, Antonio |4 oth | |
| 700 | 1 | |a González-Juanatey, José Ramón |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier España [u.a.] |a Perumal, Ekambaram ELSEVIER |t A brief review on experimental fluorosis |d 2013 |d publicación oficial de la Sociedad Española de Cardiologia |g Madrid |w (DE-627)ELV02195304X |
| 773 | 1 | 8 | |g volume:74 |g year:2021 |g number:2 |g pages:175-182 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.rec.2020.05.018 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a GBV_ILN_644 | ||
| 936 | b | k | |a 42.13 |j Molekularbiologie |q VZ |
| 936 | b | k | |a 44.33 |j Physiologische Chemie |q VZ |
| 951 | |a AR | ||
| 952 | |d 74 |j 2021 |e 2 |h 175-182 |g 8 | ||
| author_variant |
d l o dlo |
|---|---|
| matchkey_str |
lpezoterodiegolpezpaisjaviercachoantonio:2021----:matfnitnicnetnezmihbtradnitnircpobokrocvd9nws |
| hierarchy_sort_str |
2021 |
| bklnumber |
42.13 44.33 |
| publishDate |
2021 |
| allfields |
10.1016/j.rec.2020.05.018 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001275.pica (DE-627)ELV052849937 (ELSEVIER)S1885-5857(20)30224-3 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl López-Otero, Diego verfasserin aut Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers Elsevier López-Pais, Javier oth Cacho-Antonio, Carla Eugenia oth Antúnez-Muiños, Pablo José oth González-Ferrero, Teba oth Pérez-Poza, Marta oth Otero-García, Óscar oth Díaz-Fernández, Brais oth Bastos-Fernández, María oth Bouzas-Cruz, Noelia oth Sanmartín-Pena, Xoan Carlos oth Varela-Román, Alfonso oth Portela-Romero, Manuel oth Valdés-Cuadrado, Luis oth Pose-Reino, Antonio oth González-Juanatey, José Ramón oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:74 year:2021 number:2 pages:175-182 extent:8 https://doi.org/10.1016/j.rec.2020.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 74 2021 2 175-182 8 |
| spelling |
10.1016/j.rec.2020.05.018 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001275.pica (DE-627)ELV052849937 (ELSEVIER)S1885-5857(20)30224-3 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl López-Otero, Diego verfasserin aut Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers Elsevier López-Pais, Javier oth Cacho-Antonio, Carla Eugenia oth Antúnez-Muiños, Pablo José oth González-Ferrero, Teba oth Pérez-Poza, Marta oth Otero-García, Óscar oth Díaz-Fernández, Brais oth Bastos-Fernández, María oth Bouzas-Cruz, Noelia oth Sanmartín-Pena, Xoan Carlos oth Varela-Román, Alfonso oth Portela-Romero, Manuel oth Valdés-Cuadrado, Luis oth Pose-Reino, Antonio oth González-Juanatey, José Ramón oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:74 year:2021 number:2 pages:175-182 extent:8 https://doi.org/10.1016/j.rec.2020.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 74 2021 2 175-182 8 |
| allfields_unstemmed |
10.1016/j.rec.2020.05.018 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001275.pica (DE-627)ELV052849937 (ELSEVIER)S1885-5857(20)30224-3 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl López-Otero, Diego verfasserin aut Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers Elsevier López-Pais, Javier oth Cacho-Antonio, Carla Eugenia oth Antúnez-Muiños, Pablo José oth González-Ferrero, Teba oth Pérez-Poza, Marta oth Otero-García, Óscar oth Díaz-Fernández, Brais oth Bastos-Fernández, María oth Bouzas-Cruz, Noelia oth Sanmartín-Pena, Xoan Carlos oth Varela-Román, Alfonso oth Portela-Romero, Manuel oth Valdés-Cuadrado, Luis oth Pose-Reino, Antonio oth González-Juanatey, José Ramón oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:74 year:2021 number:2 pages:175-182 extent:8 https://doi.org/10.1016/j.rec.2020.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 74 2021 2 175-182 8 |
| allfieldsGer |
10.1016/j.rec.2020.05.018 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001275.pica (DE-627)ELV052849937 (ELSEVIER)S1885-5857(20)30224-3 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl López-Otero, Diego verfasserin aut Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers Elsevier López-Pais, Javier oth Cacho-Antonio, Carla Eugenia oth Antúnez-Muiños, Pablo José oth González-Ferrero, Teba oth Pérez-Poza, Marta oth Otero-García, Óscar oth Díaz-Fernández, Brais oth Bastos-Fernández, María oth Bouzas-Cruz, Noelia oth Sanmartín-Pena, Xoan Carlos oth Varela-Román, Alfonso oth Portela-Romero, Manuel oth Valdés-Cuadrado, Luis oth Pose-Reino, Antonio oth González-Juanatey, José Ramón oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:74 year:2021 number:2 pages:175-182 extent:8 https://doi.org/10.1016/j.rec.2020.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 74 2021 2 175-182 8 |
| allfieldsSound |
10.1016/j.rec.2020.05.018 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001275.pica (DE-627)ELV052849937 (ELSEVIER)S1885-5857(20)30224-3 DE-627 ger DE-627 rakwb eng 570 VZ 540 VZ 610 VZ 610 VZ 42.13 bkl 44.33 bkl López-Otero, Diego verfasserin aut Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry 2021 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers Elsevier López-Pais, Javier oth Cacho-Antonio, Carla Eugenia oth Antúnez-Muiños, Pablo José oth González-Ferrero, Teba oth Pérez-Poza, Marta oth Otero-García, Óscar oth Díaz-Fernández, Brais oth Bastos-Fernández, María oth Bouzas-Cruz, Noelia oth Sanmartín-Pena, Xoan Carlos oth Varela-Román, Alfonso oth Portela-Romero, Manuel oth Valdés-Cuadrado, Luis oth Pose-Reino, Antonio oth González-Juanatey, José Ramón oth Enthalten in Elsevier España [u.a.] Perumal, Ekambaram ELSEVIER A brief review on experimental fluorosis 2013 publicación oficial de la Sociedad Española de Cardiologia Madrid (DE-627)ELV02195304X volume:74 year:2021 number:2 pages:175-182 extent:8 https://doi.org/10.1016/j.rec.2020.05.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 74 2021 2 175-182 8 |
| language |
English |
| source |
Enthalten in A brief review on experimental fluorosis Madrid volume:74 year:2021 number:2 pages:175-182 extent:8 |
| sourceStr |
Enthalten in A brief review on experimental fluorosis Madrid volume:74 year:2021 number:2 pages:175-182 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Molekularbiologie Physiologische Chemie |
| institution |
findex.gbv.de |
| topic_facet |
Angiotensin-converting enzyme inhibitors COVID-19 Angiotensin receptor blockers |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
A brief review on experimental fluorosis |
| authorswithroles_txt_mv |
López-Otero, Diego @@aut@@ López-Pais, Javier @@oth@@ Cacho-Antonio, Carla Eugenia @@oth@@ Antúnez-Muiños, Pablo José @@oth@@ González-Ferrero, Teba @@oth@@ Pérez-Poza, Marta @@oth@@ Otero-García, Óscar @@oth@@ Díaz-Fernández, Brais @@oth@@ Bastos-Fernández, María @@oth@@ Bouzas-Cruz, Noelia @@oth@@ Sanmartín-Pena, Xoan Carlos @@oth@@ Varela-Román, Alfonso @@oth@@ Portela-Romero, Manuel @@oth@@ Valdés-Cuadrado, Luis @@oth@@ Pose-Reino, Antonio @@oth@@ González-Juanatey, José Ramón @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV02195304X |
| dewey-sort |
3570 |
| id |
ELV052849937 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV052849937</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624190338.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rec.2020.05.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001275.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV052849937</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1885-5857(20)30224-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.33</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">López-Otero, Diego</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Angiotensin-converting enzyme inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COVID-19</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Angiotensin receptor blockers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">López-Pais, Javier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cacho-Antonio, Carla Eugenia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antúnez-Muiños, Pablo José</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">González-Ferrero, Teba</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pérez-Poza, Marta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Otero-García, Óscar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Díaz-Fernández, Brais</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bastos-Fernández, María</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bouzas-Cruz, Noelia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sanmartín-Pena, Xoan Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Varela-Román, Alfonso</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Portela-Romero, Manuel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Valdés-Cuadrado, Luis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pose-Reino, Antonio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">González-Juanatey, José Ramón</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier España [u.a.]</subfield><subfield code="a">Perumal, Ekambaram ELSEVIER</subfield><subfield code="t">A brief review on experimental fluorosis</subfield><subfield code="d">2013</subfield><subfield code="d">publicación oficial de la Sociedad Española de Cardiologia</subfield><subfield code="g">Madrid</subfield><subfield code="w">(DE-627)ELV02195304X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:74</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:175-182</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rec.2020.05.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_644</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.13</subfield><subfield code="j">Molekularbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.33</subfield><subfield code="j">Physiologische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">74</subfield><subfield code="j">2021</subfield><subfield code="e">2</subfield><subfield code="h">175-182</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
López-Otero, Diego |
| spellingShingle |
López-Otero, Diego ddc 570 ddc 540 ddc 610 bkl 42.13 bkl 44.33 Elsevier Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry |
| authorStr |
López-Otero, Diego |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV02195304X |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences 610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 VZ 540 VZ 610 VZ 42.13 bkl 44.33 bkl Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers Elsevier |
| topic |
ddc 570 ddc 540 ddc 610 bkl 42.13 bkl 44.33 Elsevier Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers |
| topic_unstemmed |
ddc 570 ddc 540 ddc 610 bkl 42.13 bkl 44.33 Elsevier Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers |
| topic_browse |
ddc 570 ddc 540 ddc 610 bkl 42.13 bkl 44.33 Elsevier Angiotensin-converting enzyme inhibitors Elsevier COVID-19 Elsevier Angiotensin receptor blockers |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j l p jlp c e c a cec ceca p j a m pja pjam t g f tgf m p p mpp ó o g óog b d f bdf m b f mbf n b c nbc x c s p xcs xcsp a v r avr m p r mpr l v c lvc a p r apr j r g j jrg jrgj |
| hierarchy_parent_title |
A brief review on experimental fluorosis |
| hierarchy_parent_id |
ELV02195304X |
| dewey-tens |
570 - Life sciences; biology 540 - Chemistry 610 - Medicine & health |
| hierarchy_top_title |
A brief review on experimental fluorosis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV02195304X |
| title |
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry |
| ctrlnum |
(DE-627)ELV052849937 (ELSEVIER)S1885-5857(20)30224-3 |
| title_full |
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry |
| author_sort |
López-Otero, Diego |
| journal |
A brief review on experimental fluorosis |
| journalStr |
A brief review on experimental fluorosis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science 600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
175 |
| author_browse |
López-Otero, Diego |
| container_volume |
74 |
| physical |
8 |
| class |
570 VZ 540 VZ 610 VZ 42.13 bkl 44.33 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
López-Otero, Diego |
| doi_str_mv |
10.1016/j.rec.2020.05.018 |
| dewey-full |
570 540 610 |
| title_sort |
impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on covid-19 in a western population. cardiovid registry |
| title_auth |
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry |
| abstract |
Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. |
| abstractGer |
Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. |
| abstract_unstemmed |
Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_130 GBV_ILN_644 |
| container_issue |
2 |
| title_short |
Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry |
| url |
https://doi.org/10.1016/j.rec.2020.05.018 |
| remote_bool |
true |
| author2 |
López-Pais, Javier Cacho-Antonio, Carla Eugenia Antúnez-Muiños, Pablo José González-Ferrero, Teba Pérez-Poza, Marta Otero-García, Óscar Díaz-Fernández, Brais Bastos-Fernández, María Bouzas-Cruz, Noelia Sanmartín-Pena, Xoan Carlos Varela-Román, Alfonso Portela-Romero, Manuel Valdés-Cuadrado, Luis Pose-Reino, Antonio González-Juanatey, José Ramón |
| author2Str |
López-Pais, Javier Cacho-Antonio, Carla Eugenia Antúnez-Muiños, Pablo José González-Ferrero, Teba Pérez-Poza, Marta Otero-García, Óscar Díaz-Fernández, Brais Bastos-Fernández, María Bouzas-Cruz, Noelia Sanmartín-Pena, Xoan Carlos Varela-Román, Alfonso Portela-Romero, Manuel Valdés-Cuadrado, Luis Pose-Reino, Antonio González-Juanatey, José Ramón |
| ppnlink |
ELV02195304X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.rec.2020.05.018 |
| up_date |
2024-07-06T17:19:25.486Z |
| _version_ |
1803850995978993664 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV052849937</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624190338.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rec.2020.05.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001275.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV052849937</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1885-5857(20)30224-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.33</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">López-Otero, Diego</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Angiotensin-converting enzyme inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">COVID-19</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Angiotensin receptor blockers</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">López-Pais, Javier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cacho-Antonio, Carla Eugenia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antúnez-Muiños, Pablo José</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">González-Ferrero, Teba</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pérez-Poza, Marta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Otero-García, Óscar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Díaz-Fernández, Brais</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bastos-Fernández, María</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bouzas-Cruz, Noelia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sanmartín-Pena, Xoan Carlos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Varela-Román, Alfonso</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Portela-Romero, Manuel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Valdés-Cuadrado, Luis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pose-Reino, Antonio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">González-Juanatey, José Ramón</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier España [u.a.]</subfield><subfield code="a">Perumal, Ekambaram ELSEVIER</subfield><subfield code="t">A brief review on experimental fluorosis</subfield><subfield code="d">2013</subfield><subfield code="d">publicación oficial de la Sociedad Española de Cardiologia</subfield><subfield code="g">Madrid</subfield><subfield code="w">(DE-627)ELV02195304X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:74</subfield><subfield code="g">year:2021</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:175-182</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rec.2020.05.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_644</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.13</subfield><subfield code="j">Molekularbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.33</subfield><subfield code="j">Physiologische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">74</subfield><subfield code="j">2021</subfield><subfield code="e">2</subfield><subfield code="h">175-182</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.4003906 |